-
1
-
-
70349412099
-
Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population
-
Sakashita M, Hirota T, Harada M, et al. Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population. Int Arch Allergy Immunol 151:255-261, 2009.
-
(2009)
Int Arch Allergy Immunol
, vol.151
, pp. 255-261
-
-
Sakashita, M.1
Hirota, T.2
Harada, M.3
-
3
-
-
77956310099
-
Definition, diagnosis, and classification
-
Committee of Practical Guidance for Management of Allergic Rhinitis. 6th ed. [in Japanese]. Tokyo: Life Science
-
Committee of Practical Guidance for Management of Allergic Rhinitis. Definition, diagnosis, and classification. In Practical Guideline for the Management of Allergic Rhinitis in Japan, 6th ed. [in Japanese]. Baba K, Konno A, and Takenaka H (Eds.). Tokyo: Life Science, 59-62, 2008.
-
(2008)
Practical Guideline for the Management of Allergic Rhinitis in Japan
, pp. 59-62
-
-
Baba, K.1
Konno, A.2
Takenaka, H.3
-
4
-
-
15844426336
-
KW-4679, an antiallergic drug, inhibits the production of inflmmatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils
-
Ikemura T, Manabe H, Sasaki Y, et al. KW-4679, an antiallergic drug, inhibits the production of inflmmatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils. Int Arch Allergy Immunol 110:57-63, 1996.
-
(1996)
Int Arch Allergy Immunol
, vol.110
, pp. 57-63
-
-
Ikemura, T.1
Manabe, H.2
Sasaki, Y.3
-
5
-
-
0032510552
-
1 receptor
-
DOI 10.1016/S0014-2999(97)01620-8, PII S0014299997016208
-
Nonaka H, Otaki S, Ohshima E, et al. Unique binding pocket for KW-4679 in the histamine H1 receptor. Eur J Pharmacol 345:111-117, 1998. (Pubitemid 28179478)
-
(1998)
European Journal of Pharmacology
, vol.345
, Issue.1
, pp. 111-117
-
-
Nonaka, H.1
Otaki, S.2
Ohshima, E.3
Kono, M.4
Kase, H.5
Ohta, K.6
Fukui, H.7
Ichimura, M.8
-
6
-
-
0029960602
-
The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent
-
Yanni JM, Stephens DJ, Miller ST, et al. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/ antihistaminic agent. J Ocul Pharmacol Ther 12:389-400, 1996.
-
(1996)
J Ocul Pharmacol Ther
, vol.12
, pp. 389-400
-
-
Yanni, J.M.1
Stephens, D.J.2
Miller, S.T.3
-
7
-
-
0030427026
-
Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases
-
Sharif NA, Xu SX, Miller ST, et al. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278:1252-1261, 1996.
-
(1996)
J Pharmacol Exp Ther
, vol.278
, pp. 1252-1261
-
-
Sharif, N.A.1
Xu, S.X.2
Miller, S.T.3
-
8
-
-
28044462601
-
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis
-
Meltzer EO, Hampel FC, Ratner PH, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 95:600-606, 2005.
-
(2005)
Ann Allergy Asthma Immunol
, vol.95
, pp. 600-606
-
-
Meltzer, E.O.1
Hampel, F.C.2
Ratner, P.H.3
-
9
-
-
28044463620
-
Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar
-
Ratner PH, Hampel FC, Amar NJ, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol 95:474-479, 2005.
-
(2005)
Ann Allergy Asthma Immunol
, vol.95
, pp. 474-479
-
-
Ratner, P.H.1
Hampel, F.C.2
Amar, N.J.3
-
10
-
-
38349110611
-
Comprehensive report of the efficacy, safety, quality of life, and work impact of olopatadine 0.6% and olopatadine 0.4% treatment in patients with seasonal allergic rhinitis
-
Fairchild CJ, Meltzer EO, Roland PS, et al. Comprehensive report of the efficacy, safety, quality of life, and work impact of olopatadine 0.6% and olopatadine 0.4% treatment in patients with seasonal allergic rhinitis. Allergy Asthma Proc 2007 28:716-723, 2007.
-
(2007)
Allergy Asthma Proc 2007
, vol.28
, pp. 716-723
-
-
Fairchild, C.J.1
Meltzer, E.O.2
Roland, P.S.3
-
11
-
-
47349109362
-
The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation
-
Pipkorn P, Costantini C, Reynolds C, et al. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Ann Allergy Asthma Immunol 101:82-89, 2008. (Pubitemid 352000749)
-
(2008)
Annals of Allergy, Asthma and Immunology
, vol.101
, Issue.1
, pp. 82-89
-
-
Pipkorn, P.1
Costantini, C.2
Reynolds, C.3
Wall, M.4
Drake, M.5
Sanico, A.6
Proud, D.7
Togias, A.8
-
12
-
-
68249157077
-
Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis
-
Kaliner MA, Storms W, Tilles S, et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 μg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc 30:255-262, 2009.
-
(2009)
Allergy Asthma Proc
, vol.30
, pp. 255-262
-
-
Kaliner, M.A.1
Storms, W.2
Tilles, S.3
-
13
-
-
17444417420
-
The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen
-
Hyo S, Fujieda S, Kawada R, et al. The efficacy of short-term administration of 3 antihistamines vs placebo under natural exposure to Japanese cedar pollen. Ann Allergy Asthma Immunol 94:457-464, 2005.
-
(2005)
Ann Allergy Asthma Immunol
, vol.94
, pp. 457-464
-
-
Hyo, S.1
Fujieda, S.2
Kawada, R.3
-
14
-
-
14644396602
-
Double-blind, crossover, comparison of olopatadine and cetirizine versus placebo: Suppressive effects on skin response to histamine iontophoresis
-
Morita E, Matsuo H, and Zhang Y. Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: Suppressive effects on skin response to histamine iontophoresis. J Dermatol 32:58-61, 2005. (Pubitemid 40313066)
-
(2005)
Journal of Dermatology
, vol.32
, Issue.1
, pp. 58-61
-
-
Morita, E.1
Matsuo, H.2
Zhang, Y.3
-
15
-
-
46649087147
-
Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: A double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis
-
Takahashi H, Zhang Y, and Morita E. Evaluation of the antihistamine effects of olopatadine, cetirizine and fexofenadine during a 24 h period: A double-blind, randomized, crossover, placebo-controlled comparison in skin responses induced by histamine iontophoresis. Arch Dermatol Res 300:291-295, 2008.
-
(2008)
Arch Dermatol Res
, vol.300
, pp. 291-295
-
-
Takahashi, H.1
Zhang, Y.2
Morita, E.3
-
16
-
-
33644987428
-
Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: A comparison of olopatadine and ketotifen
-
Tashiro M, Mochizuki H, Sakurada Y, et al. Brain histamine H receptor occupancy of orally administered antihistamines measured by positron emission tomography with (11)C-doxepin in a placebo-controlled crossover study design in healthy subjects: A comparison of olopatadine and ketotifen. Br J Clin Pharmacol 61:16-26, 2006.
-
(2006)
Br J Clin Pharmacol
, vol.61
, pp. 16-26
-
-
Tashiro, M.1
Mochizuki, H.2
Sakurada, Y.3
-
17
-
-
77956298702
-
Clinical efficacy of prophylactic administration of a second-generation antihistamine to patients with Japanese cedar pollinosis: A three-year, multicenter, retrospective study
-
in Japanese
-
Fujieda S, Yamada T, Kojima A, et al. Clinical efficacy of prophylactic administration of a second-generation antihistamine to patients with Japanese cedar pollinosis: A three-year, multicenter, retrospective study [in Japanese]. Jpn J Rhinol 46:18-28, 2007.
-
(2007)
Jpn J Rhinol
, vol.46
, pp. 18-28
-
-
Fujieda, S.1
Yamada, T.2
Kojima, A.3
-
18
-
-
0034728807
-
Sedation with "nonsedating" antihistamines: Four prescription-event monitoring studies in general practice
-
Mann RD, Pearce GL, Dunn N, et al. Sedation with "nonsedating" antihistamines: Four prescription-event monitoring studies in general practice. BMJ 320:1184-1187, 2000.
-
(2000)
BMJ
, vol.320
, pp. 1184-1187
-
-
Mann, R.D.1
Pearce, G.L.2
Dunn, N.3
-
19
-
-
53749084552
-
Evaluation of efficacy and sedative profiles of H1 antihistamines by large-scale surveillance using the visual analogue scale (VAS)
-
Izumi N, Mizuguchi H, Umehara H, et al. Evaluation of efficacy and sedative profiles of H1 antihistamines by large-scale surveillance using the visual analogue scale (VAS). Allergol Int 57:257-263, 2008.
-
(2008)
Allergol Int
, vol.57
, pp. 257-263
-
-
Izumi, N.1
Mizuguchi, H.2
Umehara, H.3
-
20
-
-
1442301563
-
How significant is the role of P-glycoprotein in drug absorption and brain uptake?
-
Lin JH. How significant is the role of P-glycoprotein in drug absorption and brain uptake? Drugs Today 40:5-22, 2004.
-
(2004)
Drugs Today
, vol.40
, pp. 5-22
-
-
Lin, J.H.1
-
21
-
-
0042391834
-
Transporter-mediated drug interactions
-
Tsuji A. Transporter-mediated drug interactions. Drug Metab Pharmacokinet 17:253-274, 2002.
-
(2002)
Drug Metab Pharmacokinet
, vol.17
, pp. 253-274
-
-
Tsuji, A.1
-
22
-
-
0037372571
-
Pglycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists
-
Chen C, Hanson E, Watson JW, and Lee, JS. Pglycoprotein limits the brain penetration of nonsedating but not sedating H1-antagonists. Drug Metab Dispos 31:312-318, 2003.
-
(2003)
Drug Metab Dispos
, vol.31
, pp. 312-318
-
-
Chen, C.1
Hanson, E.2
Watson, J.W.3
Lee, J.S.4
-
23
-
-
0032793959
-
OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine
-
Cvetkovic M, Leake B, Fromm MF, et al. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine. Drug Metab Dispos 27:866-871, 1999. (Pubitemid 29347585)
-
(1999)
Drug Metabolism and Disposition
, vol.27
, Issue.8
, pp. 866-871
-
-
Cvetkovic, M.1
Leake, B.2
Fromm, M.F.3
Wilkinson, G.R.4
Kim, R.B.5
-
24
-
-
11144356916
-
Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier
-
Ishiguro N, Nozawa T, Tsujihata A, et al. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier. Drug Metab Dispos 32:519-524, 2004.
-
(2004)
Drug Metab Dispos
, vol.32
, pp. 519-524
-
-
Ishiguro, N.1
Nozawa, T.2
Tsujihata, A.3
-
25
-
-
0141507948
-
P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine
-
Polli JW, Baughman TM, Humphreys JE, et al. P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine. J Pharm Sci 92:2082-2089, 2003.
-
(2003)
J Pharm Sci
, vol.92
, pp. 2082-2089
-
-
Polli, J.W.1
Baughman, T.M.2
Humphreys, J.E.3
-
26
-
-
43749118939
-
P-glycoprotein limits the brain penetration of olopatadine hydrochloride, h1-receptor antagonist
-
MiuraI N, Nagata Y, Kuwabara T, et al. P-glycoprotein limits the brain penetration of olopatadine hydrochloride, h1-receptor antagonist. Drug Metab Pharmacokinet 23:106-114, 2008.
-
(2008)
Drug Metab Pharmacokinet
, vol.23
, pp. 106-114
-
-
MiuraI, N.1
Nagata, Y.2
Kuwabara, T.3
-
27
-
-
33745715503
-
-
Schering Corporation. Kenilworth NJ, Available online at May 5
-
Schering Corporation. Clarinex (desloratadine) product information package insert. Kenilworth NJ, 2002. Available online at www.spfiles.com/ piclarinex.pdf; May 5, 2006.
-
(2002)
Clarinex (Desloratadine) Product Information Package Insert
-
-
-
29
-
-
0035199635
-
Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen-antibody reaction in guinea pigs
-
Kaise T, Akamatsu Y, Ohmori K, et al. Effects of olopatadine hydrochloride on the release of thromboxane B2 and histamine from nasal mucosa after antigen-antibody reaction in guinea pigs. Allergol Int 50:337-341, 2001.
-
(2001)
Allergol Int
, vol.50
, pp. 337-341
-
-
Kaise, T.1
Akamatsu, Y.2
Ohmori, K.3
-
30
-
-
0035016349
-
Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs
-
Miyake K, Horikoshi K, Ikeda Y, et al. Effects of olopatadine hydrochloride on the increase of histamine and peptide-leukotrienes concentrations in nasal lavage fluid following the antigen-antibody reaction in actively sensitized guinea pigs. Jpn J Pharmacol 85:453-456, 2001. (Pubitemid 33815426)
-
(2001)
Journal of Pharmacological Sciences
, vol.85
, Issue.4
, pp. 453-456
-
-
Miyake, K.1
Horikoshi, K.2
Ikeda, Y.3
Ishii, A.4
Karasawa, A.5
-
31
-
-
0035072066
-
Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophils
-
DOI 10.1046/j.1440-1592.2001.00207.x
-
Miyake K, Ohmori K, Ishi A, et al. Inhibitory effect of olopatadine hydrochloride (KW-4679), a novel antiallergic drug, on peptide leukotriene release from human eosinophils. Allergol Int 50:113-116, 2001. (Pubitemid 32294478)
-
(2001)
Allergology International
, vol.50
, Issue.1
, pp. 113-116
-
-
Miyake, K.1
Ohmori, K.2
Ishii, A.3
Karasawa, A.4
-
32
-
-
34250795089
-
The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells
-
Yamauchi Y, Fujikura T, and Shimosawa T. The effect of H1 antagonists carebastine and olopatadine on histamine induced expression of CC chemokines in cultured human nasal epithelial cells. Allergol Int 56:171-177, 2007.
-
(2007)
Allergol Int
, vol.56
, pp. 171-177
-
-
Yamauchi, Y.1
Fujikura, T.2
Shimosawa, T.3
-
33
-
-
0035985304
-
Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils
-
DOI 10.1254/jjp.88.463
-
Fukuishi N, Matsuhisa M, Shimono T, et al. Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils. Jpn J Pharmacol 88:463-466, 2002. (Pubitemid 34516574)
-
(2002)
Japanese Journal of Pharmacology
, vol.88
, Issue.4
, pp. 463-466
-
-
Fukuishi, N.1
Matsuhisa, M.2
Shimono, T.3
Murata, N.4
Iwanaga, M.5
Sagara, H.6
Matsui, N.7
Akagi, M.8
-
34
-
-
9444250472
-
Role of substance P in the vascular response of nasal mucosa in nasal allergy
-
Konno A, Numata T, Terada N, et al. Role of substance P in the vascular response of nasal mucosa in nasal allergy. Ann Otol Rhinol Laryngol 105:648-653, 1996. (Pubitemid 26272274)
-
(1996)
Annals of Otology, Rhinology and Laryngology
, vol.105
, Issue.8
, pp. 648-653
-
-
Konno, A.1
Hanazawa, T.2
Numata, T.3
Nagata, H.4
Terada, N.5
Motosugi, H.6
-
35
-
-
28244482649
-
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis
-
Izu K, and Tokura Y. The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis. J Dermatol 32:776-781, 2005. (Pubitemid 41703752)
-
(2005)
Journal of Dermatology
, vol.32
, Issue.10
, pp. 776-781
-
-
Izu, K.1
Tokura, Y.2
-
36
-
-
66949160388
-
A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis
-
Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clin Ther 31:921-944, 2009.
-
(2009)
Clin Ther
, vol.31
, pp. 921-944
-
-
Bachert, C.1
-
37
-
-
68249155419
-
Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the burden of rhinitis in America survey
-
Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: Findings from the burden of rhinitis in America survey. Allergy Asthma Proc 30:244-254, 2009.
-
(2009)
Allergy Asthma Proc
, vol.30
, pp. 244-254
-
-
Meltzer, E.O.1
Nathan, R.2
Derebery, J.3
-
38
-
-
22944477051
-
Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires
-
Okuda M, Ohkubo K, Goto M, et al. Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol 125:736-744, 2005.
-
(2005)
Acta Otolaryngol
, vol.125
, pp. 736-744
-
-
Okuda, M.1
Ohkubo, K.2
Goto, M.3
|